552 related articles for article (PubMed ID: 22251937)
21. Genomic characterization reveals distinct mutation landscapes and therapeutic implications in neuroendocrine carcinomas of the gastrointestinal tract.
Wu H; Yu Z; Liu Y; Guo L; Teng L; Guo L; Liang L; Wang J; Gao J; Li R; Yang L; Nie X; Su D; Liang Z
Cancer Commun (Lond); 2022 Dec; 42(12):1367-1386. PubMed ID: 36264285
[TBL] [Abstract][Full Text] [Related]
22. Loss of Chromatin-Remodeling Proteins and/or CDKN2A Associates With Metastasis of Pancreatic Neuroendocrine Tumors and Reduced Patient Survival Times.
Roy S; LaFramboise WA; Liu TC; Cao D; Luvison A; Miller C; Lyons MA; O'Sullivan RJ; Zureikat AH; Hogg ME; Tsung A; Lee KK; Bahary N; Brand RE; Chennat JS; Fasanella KE; McGrath K; Nikiforova MN; Papachristou GI; Slivka A; Zeh HJ; Singhi AD
Gastroenterology; 2018 Jun; 154(8):2060-2063.e8. PubMed ID: 29486199
[TBL] [Abstract][Full Text] [Related]
23. Genomic Profiling of Large-Cell Neuroendocrine Carcinoma of the Lung.
Miyoshi T; Umemura S; Matsumura Y; Mimaki S; Tada S; Makinoshima H; Ishii G; Udagawa H; Matsumoto S; Yoh K; Niho S; Ohmatsu H; Aokage K; Hishida T; Yoshida J; Nagai K; Goto K; Tsuboi M; Tsuchihara K
Clin Cancer Res; 2017 Feb; 23(3):757-765. PubMed ID: 27507618
[TBL] [Abstract][Full Text] [Related]
24. Overview of the 2022 WHO Classification of Neuroendocrine Neoplasms.
Rindi G; Mete O; Uccella S; Basturk O; La Rosa S; Brosens LAA; Ezzat S; de Herder WW; Klimstra DS; Papotti M; Asa SL
Endocr Pathol; 2022 Mar; 33(1):115-154. PubMed ID: 35294740
[TBL] [Abstract][Full Text] [Related]
25. Well-differentiated pancreatic neuroendocrine tumours (PanNETs) and poorly differentiated pancreatic neuroendocrine carcinomas (PanNECs): concepts, issues and a practical diagnostic approach to high-grade (G3) cases.
Singhi AD; Klimstra DS
Histopathology; 2018 Jan; 72(1):168-177. PubMed ID: 29239037
[TBL] [Abstract][Full Text] [Related]
26. Clinicopathologic and Molecular Characterization of Anorectal Neuroendocrine Carcinomas Reveals Human Papillomavirus, p53, and c-Myc as Alternative Mechanisms of Carcinogenesis.
Cox AJ; Crowe WE; Yang Q; Zhang B; Oltvai ZN; Liao X
Mod Pathol; 2023 Nov; 36(11):100295. PubMed ID: 37517480
[TBL] [Abstract][Full Text] [Related]
27. The landscape of molecular alterations in pancreatic and small intestinal neuroendocrine tumours.
Scarpa A
Ann Endocrinol (Paris); 2019 Jun; 80(3):153-158. PubMed ID: 31072588
[TBL] [Abstract][Full Text] [Related]
28. Grading of Neuroendocrine Carcinomas: Correlation of
Liverani C; Bongiovanni A; Mercatali L; Foca F; Pieri F; De Vita A; Spadazzi C; Miserocchi G; Recine F; Riva N; Nicolini S; Severi S; Martinelli G; Ibrahim T
Dis Markers; 2018; 2018():6878409. PubMed ID: 30627226
[TBL] [Abstract][Full Text] [Related]
29. Comparison between neuroendocrine carcinomas and well-differentiated neuroendocrine tumors of the pancreas using dynamic enhanced CT.
Park HJ; Kim HJ; Kim KW; Kim SY; Choi SH; You MW; Hwang HS; Hong SM
Eur Radiol; 2020 Sep; 30(9):4772-4782. PubMed ID: 32346794
[TBL] [Abstract][Full Text] [Related]
30. Gastroenteropancreatic High-Grade Neuroendocrine Neoplasms: Histology and Molecular Analysis, Two Sides of the Same Coin.
Busico A; Maisonneuve P; Prinzi N; Pusceddu S; Centonze G; Garzone G; Pellegrinelli A; Giacomelli L; Mangogna A; Paolino C; Belfiore A; Kankava K; Perrone F; Tamborini E; Pruneri G; Fazio N; Milione M
Neuroendocrinology; 2020; 110(7-8):616-629. PubMed ID: 31557757
[TBL] [Abstract][Full Text] [Related]
31. HPV-associated neuroendocrine carcinomas of the head and neck in FNA biopsies: Clinicopathologic features of a rare entity.
Jo VY; Krane JF; Pantanowitz L; Monaco SE
Cancer Cytopathol; 2019 Feb; 127(1):26-34. PubMed ID: 30475447
[TBL] [Abstract][Full Text] [Related]
32. Neuroendocrine Carcinomas of the Gallbladder: A Clinicopathologic and Immunohistochemical Analysis of 34 Resected Cases.
Lee SM; Sung CO
Am J Surg Pathol; 2020 Oct; 44(10):1308-1321. PubMed ID: 32739935
[TBL] [Abstract][Full Text] [Related]
33. Study of clinicopathological features, hormone immunoexpression, and loss of ATRX and DAXX expression in pancreatic neuroendocrine tumors.
Yadav R; Kakkar A; Sharma A; Malik PS; Sharma MC
Scand J Gastroenterol; 2016 Aug; 51(8):994-9. PubMed ID: 27162024
[TBL] [Abstract][Full Text] [Related]
34. Identification of high-risk human papillomavirus and Rb/E2F pathway genomic alterations in mutually exclusive subsets of colorectal neuroendocrine carcinoma.
Shamir ER; Devine WP; Pekmezci M; Umetsu SE; Krings G; Federman S; Cho SJ; Saunders TA; Jen KY; Bergsland E; Jones K; Kim GE; Kakar S; Chiu CY; Joseph NM
Mod Pathol; 2019 Feb; 32(2):290-305. PubMed ID: 30237525
[TBL] [Abstract][Full Text] [Related]
35. Comparative study of lung and extrapulmonary poorly differentiated neuroendocrine carcinomas: A SEER database analysis of 162,983 cases.
Dasari A; Mehta K; Byers LA; Sorbye H; Yao JC
Cancer; 2018 Feb; 124(4):807-815. PubMed ID: 29211313
[TBL] [Abstract][Full Text] [Related]
36. Distinction of pulmonary large cell neuroendocrine carcinoma from small cell lung carcinoma: a morphological, immunohistochemical, and molecular analysis.
Hiroshima K; Iyoda A; Shida T; Shibuya K; Iizasa T; Kishi H; Tanizawa T; Fujisawa T; Nakatani Y
Mod Pathol; 2006 Oct; 19(10):1358-68. PubMed ID: 16862075
[TBL] [Abstract][Full Text] [Related]
37. Pancreatic Neuroendocrine Neoplasms: Basic Biology, Current Treatment Strategies and Prospects for the Future.
Ohmoto A; Rokutan H; Yachida S
Int J Mol Sci; 2017 Jan; 18(1):. PubMed ID: 28098761
[TBL] [Abstract][Full Text] [Related]
38. P53 Gene Mutation Identified by Next Generation Sequencing in Poorly Differentiated Neuroendocrine Carcinoma of the Nasal Cavity.
Wasserman JK; AlGhamdi D; de Almeida JR; Stockley TL; Perez-Ordonez B
Head Neck Pathol; 2019 Sep; 13(3):516-522. PubMed ID: 29845478
[TBL] [Abstract][Full Text] [Related]
39. Comprehensive analysis of mutational and clinicopathologic characteristics of poorly differentiated colorectal neuroendocrine carcinomas.
Lee SM; Sung CO
Sci Rep; 2021 Mar; 11(1):6203. PubMed ID: 33737597
[TBL] [Abstract][Full Text] [Related]
40. Comprehensive Genomic Profiling of Neuroendocrine Carcinomas of the Gastrointestinal System.
Yachida S; Totoki Y; Noë M; Nakatani Y; Horie M; Kawasaki K; Nakamura H; Saito-Adachi M; Suzuki M; Takai E; Hama N; Higuchi R; Hirono S; Shiba S; Kato M; Furukawa E; Arai Y; Rokutan H; Hashimoto T; Mitsunaga S; Kanda M; Tanaka H; Takata S; Shimomura A; Oshima M; Hackeng WM; Okumura T; Okano K; Yamamoto M; Yamaue H; Morizane C; Arihiro K; Furukawa T; Sato T; Kiyono T; Brosens LAA; Wood LD; Hruban RH; Shibata T
Cancer Discov; 2022 Mar; 12(3):692-711. PubMed ID: 34880079
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
